Emily Jeffcott joined Morgan & Morgan’s Pensacola office in 2019 as a trial attorney. Her practice areas extend primarily to pharmaceutical litigation. Ms. Jeffcott brings to Morgan & Morgan her experience serving as trial counsel in the prior four Xarelto bellwether trials, which included examining science and regulatory experts while simultaneously handling briefing requirements during trial. Ms. Jeffcott is also a member of the Plaintiffs’ Steering Committee for the Taxotere MDL, serving as co-chair for the law & briefing committee and a member of the science committee. Ms. Jeffcott has also served on the law & briefing committee for the Zofran MDL litigation. Her past experience also includes the FEMA Trailer Products Liability Litigation, MDL No. 1873 and the Deepwater Horizon Oil Spill, MDL No. 2179.
Ms. Jeffcott has also represented whistleblowers across the country. Prior to joining Morgan & Morgan, Ms. Jeffcott was lead counsel for Relators in a $150 million qui tam settlement against Bechtel and AECOM for false claims related to the Hanford Nuclear Waste Treatment Plant in Washington. Ms. Jeffcott has also litigated cases involving Medicare fraud.
A 2009 graduate of St. Mary’s University School of Law, Ms. Jeffcott received numerous accolades for her oral advocacy skills and brief writing, including being named the top advocate of her law school class and ABA’s third-best advocate in the United States. An avid reader and writer, Ms. Jeffcott publishes regularly in legal journals and magazines distributed worldwide.